Royal Bank Of Canada Ideaya Biosciences, Inc. Transaction History

Royal Bank Of Canada

$425 Billion
Q2 2024

A detailed history of Royal Bank Of Canada transactions in Ideaya Biosciences, Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 90,482 shares of IDYA stock, worth $2.87 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

90,482

Previous 53,724 68.42%

Holding current value

$2.87 Million

Previous $2.36 Million 34.75%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$34.37 - $43.46 $1.26 Million - $1.6 Million	36,758 Added 68.42%	90,482 $3.18 Million
Q1 2024 May 15, 2024	BUY	$34.2 - $47.13 $1.21 Million - $1.67 Million	35,332 Added 192.11%	53,724 $2.36 Million
Q4 2023 Feb 14, 2024	BUY	$24.59 - $35.83 $259,596 - $378,257	10,557 Added 134.74%	18,392 $654,000
Q3 2023 Nov 14, 2023	BUY	$21.07 - $29.77 $72,249 - $102,081	3,429 Added 77.83%	7,835 $211,000
Q2 2023 Aug 14, 2023	SELL	$13.33 - $25.53 $304,270 - $582,747	-22,826 Reduced 83.82%	4,406 $103,000
Q1 2023 May 15, 2023	BUY	$13.49 - $18.72 $5,328 - $7,394	395 Added 1.47%	27,232 $373,000
Q4 2022 Feb 14, 2023	BUY	$14.47 - $18.17 $381,790 - $479,415	26,385 Added 5837.39%	26,837 $487,000
Q3 2022 Nov 14, 2022	SELL	$9.24 - $15.79 $1,552 - $2,652	-168 Reduced 27.1%	452 $6,000
Q2 2022 Aug 15, 2022	SELL	$8.28 - $13.88 $11,699 - $19,612	-1,413 Reduced 69.5%	620 $9,000
Q1 2022 May 16, 2022	SELL	$11.18 - $24.02 $51,148 - $109,891	-4,575 Reduced 69.23%	2,033 $23,000
Q4 2021 Feb 14, 2022	BUY	$20.95 - $26.88 $64,609 - $82,897	3,084 Added 87.51%	6,608 $156,000
Q3 2021 Nov 15, 2021	BUY	$17.26 - $27.08 $27,529 - $43,192	1,595 Added 82.69%	3,524 $90,000
Q2 2021 Aug 16, 2021	BUY	$17.76 - $24.83 $34,259 - $47,897	1,929 New	1,929 $40,000

Others Institutions Holding IDYA

# of Institutions

206

Shares Held

73.6M

Call Options Held

21.5K

Put Options Held

20.3K

View Full List

About IDEAYA Biosciences, Inc.

Ticker IDYA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,067,700
Market Cap $1.52B
Description
IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...

More about IDYA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Account

Royal Bank Of Canada Ideaya Biosciences, Inc. Transaction History